Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AVEXIS-INC-26304175/news/AveXis-Announces-First-Patient-Dosed-in-Phase-3-Trial-of-AVXS-101-in-Pre-Symptomatic-SMA-Types-1-2-26424602/?utm_source=whatsapp&utm_medium=social&utm_campaign=share